Standard Operating Procedure: Implementation of Quasi-Experimental Studies

This Standard Operating Procedure (SOP) outlines the essential rigorous framework for conducting quasi-experimental studies. Unlike randomized controlled trials (RCTs), quasi-experimental designs lack random assignment to treatment and control groups. Consequently, they require meticulous attention to baseline equivalence, selection bias mitigation, and robust statistical control to ensure internal validity. This document serves as a guide for researchers and operations managers to maintain data integrity and methodological transparency throughout the study lifecycle.

Phase 1: Research Design and Group Allocation

• Define the counterfactual: Clearly articulate what the control group represents in the absence of the intervention.
• Select the appropriate design type (e.g., Non-equivalent Groups Design, Regression Discontinuity, or Interrupted Time Series).
• Document the criteria for group assignment, acknowledging why randomization was not feasible or ethical.
• Establish baseline measures: Collect pre-intervention data for both treatment and comparison groups to adjust for pre-existing differences.

Phase 2: Selection Bias Mitigation

• Identify potential confounding variables that could influence the outcome independently of the intervention.
• Implement matching techniques (e.g., Propensity Score Matching) to create a comparable control group.
• Conduct sensitivity analyses to determine how strongly a hidden confounder would need to influence the results to negate the findings.
• Assess the "parallel trends" assumption if using a Difference-in-Differences (DiD) approach.

Phase 3: Data Collection and Execution

• Ensure data collection instruments are consistent across both treatment and control sites.
• Establish strict protocols for data entry to minimize observer bias.
• Monitor for "spillover effects"—ensure the control group is not being inadvertently influenced by the treatment.
• Record all "history effects" (external events occurring during the study period that might skew results).

Phase 4: Analysis and Reporting

• Apply appropriate statistical controls, such as ANCOVA or multivariate regression, to account for baseline imbalances.
• Report effect sizes alongside p-values to provide context on the practical significance of the findings.
• Explicitly state the limitations of the design, particularly the inability to establish definitive causality.
• Include a flow diagram (e.g., CONSORT-style) showing the participant recruitment and retention paths.

Pro Tips & Pitfalls

• Pro Tip: Use "Double-Robust Estimation" methods, which combine regression modeling with propensity score weighting to reduce bias even if one of the models is slightly misspecified.
• Pitfall: Avoid "Post-hoc Rationalization." Do not attempt to frame a study as quasi-experimental after failing to implement a planned RCT; the design must be intentional to manage threats to validity properly.
• Pro Tip: In Interrupted Time Series (ITS) designs, ensure you have sufficient data points (ideally 10+ pre-intervention and 10+ post-intervention) to detect a statistically significant change in slope or level.
• Pitfall: Ignoring "Attrition Bias." If individuals drop out of the treatment group at a higher rate than the control group due to the intervention itself, your final results will be significantly skewed.

Frequently Asked Questions (FAQ)

1. How is a quasi-experimental study different from an observational study? While both lack random assignment, quasi-experimental studies involve an active manipulation of an independent variable (the intervention) by the researcher. In pure observational studies, the researcher only observes existing variables without intervening.

2. Is it possible to claim causality in a quasi-experimental study? You cannot claim the same level of definitive causality as an RCT. However, by using rigorous statistical adjustments and quasi-experimental designs (like Regression Discontinuity), you can make a strong argument for a causal relationship by systematically ruling out alternative explanations.

3. What is the biggest threat to internal validity in this study type? Selection bias—the possibility that the groups were different at the start—is the primary threat. If the treatment and control groups differ in ways that correlate with the outcome, the results may be attributed to the intervention when they are actually due to pre-existing characteristics.